These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 27240147)
1. HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines. Calmon MF; Sichero L; Boccardo E; Villa LL; Rahal P Virology; 2016 Sep; 496():35-41. PubMed ID: 27240147 [TBL] [Abstract][Full Text] [Related]
2. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
3. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes. Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766 [TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). McFarlane M; MacDonald AI; Stevenson A; Graham SV J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103 [TBL] [Abstract][Full Text] [Related]
6. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells. Bai L; Wei L; Wang J; Li X; He P Int J Gynecol Cancer; 2006; 16(2):718-29. PubMed ID: 16681752 [TBL] [Abstract][Full Text] [Related]
7. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Au Yeung CL; Tsang WP; Tsang TY; Co NN; Yau PL; Kwok TT Oncol Rep; 2010 Dec; 24(6):1599-604. PubMed ID: 21042757 [TBL] [Abstract][Full Text] [Related]
8. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
9. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines. Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329 [TBL] [Abstract][Full Text] [Related]
10. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. Diaz D; Santander MA; Chavez JA Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553 [TBL] [Abstract][Full Text] [Related]
11. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer. Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046 [TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375 [TBL] [Abstract][Full Text] [Related]
13. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633 [TBL] [Abstract][Full Text] [Related]
14. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells. Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692 [TBL] [Abstract][Full Text] [Related]
15. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7. Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635 [TBL] [Abstract][Full Text] [Related]
16. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma]. Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346 [TBL] [Abstract][Full Text] [Related]
17. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538 [TBL] [Abstract][Full Text] [Related]
18. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640 [TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity. Thatte J; Banks L J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500 [TBL] [Abstract][Full Text] [Related]
20. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma. Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]